GHRS20261016C12.5
GHRS Oct 16 2026 12.50 Call (GHRS261016C00012500)
option OPRA

Inactive

May 26, 2026

11.00+7.422%(+0.76)10

Headquarters

Dublin, Leinster, Ireland

Industry

Biotechnology

Sector

Healthcare

Profile

gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.

Share

Connect with us

.dark-mode .Rjtzyq{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Rjtzyq{ color: #333333; background-color: white; border: 2px solid #333333; }GHRS20261016C12.5GHRS Oct 16 2026 12.50 Call (GHRS261016C00012500)option OPRA